Through the Institute's testing and evaluation activities, NIBSC's scientists help to ensure the safety and efficacy of biological products while helping to minimise the time taken to bring new products into clinical use. New products, such as the latest generation of combination vaccines, have required novel approaches for their control and development of new testing methods. Information on the wide range of research is further detailed within NIBSC scientific highlights and key targets and can be found within the NIBSC website. The vast potential increase in the numbers and complexity of biologicals, as a result of the genomics revolution will demand yet more radical control strategies.

NIBSC carries out an active high quality research programme directly related to its strategic aims, carried out by internationally respected scientists, attracting significant external funding and generating an impressive publication output.